June 23, 2022, Leap Therapeutics Inc. (NASDAQ: LPTX) trading session started at the price of $1.06, that was 18.27% jump from the session before. During the day, the shares moved up to $1.24 and dropped to $1.06 before settling in for the closing price of $1.04. A 52-week range for LPTX has been $0.92 – $4.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
When this article was written, the company’s average yearly earnings per share was at 25.40%. With a float of $70.67 million, this company’s outstanding shares have now reached $88.32 million.
Considering the fact that the conglomerate employs 36 people, you should pay attention to its efficiency factor.
Leap Therapeutics Inc. (LPTX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Leap Therapeutics Inc. stocks. The insider ownership of Leap Therapeutics Inc. is 10.38%, while institutional ownership is 49.50%.
Leap Therapeutics Inc. (LPTX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 3/30/2022, it has been observed that the corporation posted -$0.09 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.1) by $0.01. This company achieved a net margin of -2705.80 while generating a return on equity of -52.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.49% during the next five years compared to 29.60% growth over the previous five years of trading.
Leap Therapeutics Inc. (NASDAQ: LPTX) Trading Performance Indicators
You can see what Leap Therapeutics Inc. (LPTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 95.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.45 in one year’s time.
Technical Analysis of Leap Therapeutics Inc. (LPTX)
Compared to the last year’s volume of 1.12 million, its volume of 0.62 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 65.11%. Additionally, its Average True Range was 0.12.
During the past 100 days, Leap Therapeutics Inc.’s (LPTX) raw stochastic average was set at 18.79%, which indicates a significant decrease from 96.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.16% in the past 14 days, which was higher than the 99.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2315, while its 200-day Moving Average is $2.1522. Nevertheless, the first resistance level for the watch stands at $1.2933 in the near term. At $1.3567, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4733. If the price goes on to break the first support level at $1.1133, it is likely to go to the next support level at $0.9967. Now, if the price goes above the second support level, the third support stands at $0.9333.
Leap Therapeutics Inc. (NASDAQ: LPTX) Key Stats
There are 88,318K outstanding shares of the company, which has a market capitalization of 105.34 million. As of now, sales total 1,500 K while income totals -40,590 K. Its latest quarter income was 380 K while its last quarter net income were -10,790 K.